Amundi S.A.
Amundi S.A. (AMUN.PA) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Amundi S.A. (AMUN.PA), covering cash flow, earnings, and balance sheets.
Amundi S.A. (AMUN.PA) Income Statement & Financial Overview
View the income breakdown for Amundi S.A. AMUN.PA across both annual and quarterly reports.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $924.00M | $862.00M | $3.10B | $825.00M |
Cost of Revenue | $482.00M | $456.00M | $461.00M | $439.00M |
Gross Profit | $442.00M | $406.00M | $2.64B | $386.00M |
Gross Profit Ratio | $0.48 | $0.47 | $0.85 | $0.47 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $0.00 | $12.00M | $0.00 |
Operating Expenses | -$1.00M | $0.00 | $12.00M | $28.00M |
Total Costs & Expenses | $481.00M | $456.00M | $473.00M | $467.00M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $9.81M | $9.81M | $44.33M | $9.81M |
EBITDA | $433.81M | $398.81M | $880.32M | $0.00 |
EBITDA Ratio | $0.47 | $0.46 | $0.28 | $0.00 |
Operating Income | $443.00M | $406.00M | $836.00M | $386.00M |
Operating Income Ratio | $0.48 | $0.47 | $0.27 | $0.47 |
Other Income/Expenses (Net) | -$2.00M | $14.00M | -$73.76M | $28.00M |
Income Before Tax | $441.00M | $420.00M | $762.23M | $414.00M |
Income Before Tax Ratio | $0.48 | $0.49 | $0.25 | $0.50 |
Income Tax Expense | $93.00M | $101.00M | $188.73M | $97.00M |
Net Income | $349.00M | $320.00M | $317.97M | $318.00M |
Net Income Ratio | $0.38 | $0.37 | $0.10 | $0.39 |
EPS | $1.70 | $1.56 | $3.11 | $1.55 |
Diluted EPS | $1.70 | $1.56 | $3.11 | $1.55 |
Weighted Avg Shares Outstanding | $204.78M | $204.65M | $203.68M | $204.73M |
Weighted Avg Shares Outstanding (Diluted) | $204.78M | $204.65M | $203.68M | $204.73M |
Over the last four quarters, Amundi S.A. achieved steady financial progress, growing revenue from $825.00M in Q1 2024 to $924.00M in Q4 2024. Gross profit stayed firm with margins at 48% in Q4 2024 versus 47% in Q1 2024. Operating income totaled $443.00M in Q4 2024, maintaining a 48% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $433.81M. Net income rose to $349.00M, with EPS at $1.70. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan